 Athenex, Inc. NASDAQ:ATNX Q1 2022 Earnings Conference Call May 10, 2022 8:00 AM ET Company Participants Caileigh Dougherty - Investor Relations Johnson Lau - Chief Executive Officer Daniel Lang - President, Athenex Cell Therapy Jeffrey Yordon - Chief Operating Officer Joe Annoni - Chief Financial Officer Kurt Gunter - Chief Medical Officer, Cell Therapy and Head of Regulatory Affairs Conference Call Participants Kevin DeGeeter - Oppenheimer Co. Robyn Karnauskas - Truist Securities Jonathan Chang - SVB Leerink Yale Jen - Laidlaw Company Operator Good day, ladies and gentlemen, and welcome to the First Quarter 2022 Athenex Earnings Conference Call. After the presentation, there will be an opportunity to ask questions. 